ProShare Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$507K	Sell	21,499 -4,026	-16%	-$103K	﹤0.01%	1055
2025 Q4	$741K	Buy	25,525 +2,941	+13%	+$75.3K	﹤0.01%	925
2025 Q3	$426K	Sell	22,584 -3,830	-14%	-$60.4K	﹤0.01%	1202
2025 Q2	$370K	Sell	26,414 -2,208	-8%	-$31K	﹤0.01%	1296
2025 Q1	$448K	Sell	28,622 -7,195	-20%	-$101K	﹤0.01%	1155
2024 Q4	$499K	Buy	35,817 +8,833	+33%	+$96.8K	﹤0.01%	1276
2024 Q3	$251K	Buy	26,984 +9,245	+52%	+$91.2K	﹤0.01%	1582
2024 Q2	$165K	Sell	17,739 -3,251	-15%	-$29.4K	﹤0.01%	1572
2024 Q1	$208K	Buy	20,990 +1,870	+10%	+$14K	﹤0.01%	1652
2023 Q4	$61.8K	Buy	19,120 +8,412	+79%	+$22.9K	﹤0.01%	1837
2023 Q3	$56.9K	Buy	10,708 +47	+0.4%	+$400	﹤0.01%	1702
2023 Q2	$102K	Buy	+10,661	New	+$118K	﹤0.01%	1696
2023 Q1	–	Sell	-10,379	Closed	-$154K	–	1797
2022 Q4	$154K	Buy	+10,379	New	+$181K	﹤0.01%	1557
2022 Q2	–	Sell	-10,401	Closed	-$200K	–	1813
2022 Q1	$200K	Sell	10,401 -2,726	-21%	-$46.1K	﹤0.01%	1888
2021 Q4	$272K	Sell	13,127 -1,148	-8%	-$22.9K	﹤0.01%	1844
2021 Q3	$341K	Sell	14,275 -1,922	-12%	-$43.8K	﹤0.01%	1454
2021 Q2	$442K	Buy	16,197 +3,069	+23%	+$86.4K	﹤0.01%	1616
2021 Q1	$380K	Buy	13,128 +1,809	+16%	+$56.5K	﹤0.01%	1642
2020 Q4	$318K	Buy	+11,319	New	+$277K	﹤0.01%	1570